Coadministration of voriconazole and phenytoin: pharmacokinetic interaction, safety, and toleration.
- Published in:
- British Journal of Clinical Pharmacology, 2003, v. 56, p. 37, doi. 10.1046/j.1365-2125.2003.01997.x
- By:
- Publication type:
- Article
Works matching IS 03065251 AND DT 2003 AND VI 56
Results: 131
1
2
The pharmacokinetics of voriconazole.
- Published in:
- 2003
- By:
- Publication type:
- Editorial
3
Voriconazole, a novel wide-spectrum triazole: oral pharmacokinetics and safety.
- Published in:
- British Journal of Clinical Pharmacology, 2003, v. 56, p. 10, doi. 10.1046/j.1365-2125.2003.01993.x
- By:
- Publication type:
- Article
4
Effect of food on the pharmacokinetics of multiple-dose oral voriconazole.
- Published in:
- British Journal of Clinical Pharmacology, 2003, v. 56, p. 17, doi. 10.1046/j.1365-2125.2003.01994.x
- By:
- Publication type:
- Article
5
Voriconazole potentiates warfarin-induced prothrombin time prolongation.
- Published in:
- British Journal of Clinical Pharmacology, 2003, v. 56, p. 24, doi. 10.1046/j.1365-2125.2003.01995.x
- By:
- Publication type:
- Article
6
No clinically significant effect of erythromycin or azithromycin on the pharmacokinetics of voriconazole in healthy male volunteers.
- Published in:
- British Journal of Clinical Pharmacology, 2003, v. 56, p. 30, doi. 10.1046/j.1365-2125.2003.01996.x
- By:
- Publication type:
- Article
7
The pharmacokinetics and safety of intravenous voriconazole – a novel wide-spectrum antifungal agent.
- Published in:
- British Journal of Clinical Pharmacology, 2003, v. 56, p. 2, doi. 10.1046/j.1365-2125.2003.01992.x
- By:
- Publication type:
- Article
8
Voriconazole does not affect the steady-state pharmacokinetics of digoxin.
- Published in:
- British Journal of Clinical Pharmacology, 2003, v. 56, p. 45, doi. 10.1046/j.1365-2125.2003.01998.x
- By:
- Publication type:
- Article
9
Histamine H<sub>2</sub>-receptor antagonists have no clinically significant effect on the steady-state pharmacokinetics of voriconazole.
- Published in:
- British Journal of Clinical Pharmacology, 2003, v. 56, p. 51, doi. 10.1046/j.1365-2125.2003.01999.x
- By:
- Publication type:
- Article
10
Effect of omeprazole on the steady-state pharmacokinetics of voriconazole.
- Published in:
- British Journal of Clinical Pharmacology, 2003, v. 56, p. 56, doi. 10.1046/j.1365-2125.2003.02000.x
- By:
- Publication type:
- Article
11
No clinically significant pharmacokinetic interactions between voriconazole and indinavir in healthy volunteers.
- Published in:
- British Journal of Clinical Pharmacology, 2003, v. 56, p. 62, doi. 10.1046/j.1365-2125.2003.02001.x
- By:
- Publication type:
- Article
12
Pulmonary drug delivery. Part I: Physiological factors affecting therapeutic effectiveness of aerosolized medications.
- Published in:
- British Journal of Clinical Pharmacology, 2003, v. 56, n. 6, p. 588, doi. 10.1046/j.1365-2125.2003.01892.x
- By:
- Publication type:
- Article
13
Pulmonary drug delivery. Part II: The role of inhalant delivery devices and drug formulations in therapeutic effectiveness of aerosolized medications.
- Published in:
- British Journal of Clinical Pharmacology, 2003, v. 56, n. 6, p. 600, doi. 10.1046/j.1365-2125.2003.01893.x
- By:
- Publication type:
- Article
14
The involvement of nurses in reporting suspected adverse drug reactions: experience with the meningococcal vaccination scheme.
- Published in:
- British Journal of Clinical Pharmacology, 2003, v. 56, n. 6, p. 658, doi. 10.1046/j.1365-2125.2003.01903.x
- By:
- Publication type:
- Article
15
Replacement therapy for vitamin B12 deficiency: comparison between the sublingual and oral route.
- Published in:
- British Journal of Clinical Pharmacology, 2003, v. 56, n. 6, p. 635, doi. 10.1046/j.1365-2125.2003.01907.x
- By:
- Publication type:
- Article
16
Diltiazem co-treatment in renal transplant patients receiving microemulsion cyclosporin.
- Published in:
- British Journal of Clinical Pharmacology, 2003, v. 56, n. 6, p. 670, doi. 10.1046/j.1365-2125.2003.01908.x
- By:
- Publication type:
- Article
17
Differential binding of disopyramide and warfarin enantiomers to human α<sub>1</sub>-acid glycoprotein variants.
- Published in:
- British Journal of Clinical Pharmacology, 2003, v. 56, n. 6, p. 664, doi. 10.1046/j.1365-2125.2003.01909.x
- By:
- Publication type:
- Article
18
The epidemiology of self-poisoning in the UK.
- Published in:
- British Journal of Clinical Pharmacology, 2003, v. 56, n. 6, p. 613, doi. 10.1046/j.1365-2125.2003.01910.x
- By:
- Publication type:
- Article
19
Population pharmacokinetics of ceftazidime in burn patients.
- Published in:
- British Journal of Clinical Pharmacology, 2003, v. 56, n. 6, p. 629, doi. 10.1046/j.1365-2125.2003.01915.x
- By:
- Publication type:
- Article
20
Book review Clinical Pharmacology.
- Published in:
- 2003
- By:
- Publication type:
- Book Review
21
Effects of caffeine intake on the pharmacokinetics of melatonin, a probe drug for CYP1A2 activity.
- Published in:
- British Journal of Clinical Pharmacology, 2003, v. 56, n. 6, p. 679, doi. 10.1046/j.1365-2125.2003.01933.x
- By:
- Publication type:
- Article
22
Letter to the Editors Lead poisoning by self-administration in an exposed worker.
- Published in:
- 2003
- By:
- Publication type:
- Letter
23
Genetic polymorphisms of CYP2C9 and CYP2C19 in the Beninese and Belgian populations.
- Published in:
- British Journal of Clinical Pharmacology, 2003, v. 56, n. 6, p. 653, doi. 10.1046/j.1365-2125.2003.01937.x
- By:
- Publication type:
- Article
24
Bioavailability of dexmedetomidine after extravascular doses in healthy subjects.
- Published in:
- British Journal of Clinical Pharmacology, 2003, v. 56, n. 6, p. 691, doi. 10.1046/j.1365-2125.2003.01944.x
- By:
- Publication type:
- Article
25
Subject Index.
- Published in:
- British Journal of Clinical Pharmacology, 2003, v. 56, n. 6, p. 705, doi. 10.1046/j.1365-2125.2003.02037b.x
- Publication type:
- Article
26
Nitrate tolerance and the links with endothelial dysfunction and oxidative stress.
- Published in:
- British Journal of Clinical Pharmacology, 2003, v. 56, n. 6, p. 620, doi. 10.1046/j.1365-2125.2003.01946.x
- By:
- Publication type:
- Article
27
Interaction of St John's wort with low-dose oral contraceptive therapy: a randomized controlled trial.
- Published in:
- British Journal of Clinical Pharmacology, 2003, v. 56, n. 6, p. 683, doi. 10.1046/j.1365-2125.2003.02005.x
- By:
- Publication type:
- Article
28
Editors’ View Nurse prescribers & reporters.
- Published in:
- British Journal of Clinical Pharmacology, 2003, v. 56, n. 6, p. 585, doi. 10.1046/j.1365-2125.2003.02023.x
- By:
- Publication type:
- Article
29
Announcement.
- Published in:
- British Journal of Clinical Pharmacology, 2003, v. 56, n. 6, p. 698, doi. 10.1046/j.1365-2125.2003.02025.x
- Publication type:
- Article
30
Author Index.
- Published in:
- British Journal of Clinical Pharmacology, 2003, v. 56, n. 6, p. 699, doi. 10.1046/j.1365-2125.2003.02037a.x
- Publication type:
- Article
31
Population pharmacokinetic modelling of darifenacin and its hydroxylated metabolite using pooled data, incorporating saturable first-pass metabolism, CYP2D6 genotype and formulation-dependent bioavailability.
- Published in:
- British Journal of Clinical Pharmacology, 2003, v. 56, n. 6, p. 639, doi. 10.1046/j.1365-2125.2003.01967.x
- By:
- Publication type:
- Article
32
Comparison of combination inhalers vs inhaled corticosteroids alone in moderate persistent asthma.
- Published in:
- British Journal of Clinical Pharmacology, 2003, v. 56, n. 5, p. 494, doi. 10.1046/j.1365-2125.2003.01887.x
- By:
- Publication type:
- Article
33
Ultramolecular homeopathy has no observable clinical effects. A randomized, double-blind, placebo-controlled proving trial of Belladonna 30C.
- Published in:
- British Journal of Clinical Pharmacology, 2003, v. 56, n. 5, p. 562, doi. 10.1046/j.1365-2125.2003.01900.x
- By:
- Publication type:
- Article
34
Dose estimation for children.
- Published in:
- British Journal of Clinical Pharmacology, 2003, v. 56, n. 5, p. 489, doi. 10.1046/j.1365-2125.2003.01901.x
- By:
- Publication type:
- Article
35
Effect of the second-generation antihistamine, fexofenadine, on cough reflex sensitivity and pulmonary function.
- Published in:
- British Journal of Clinical Pharmacology, 2003, v. 56, n. 5, p. 501, doi. 10.1046/j.1365-2125.2003.01902.x
- By:
- Publication type:
- Article
36
Changes in antipsychotic drug prescribing by general practitioners in the United Kingdom from 1991 to 2000: a population-based observational study.
- Published in:
- British Journal of Clinical Pharmacology, 2003, v. 56, n. 5, p. 569, doi. 10.1046/j.1365-2125.2003.01905.x
- By:
- Publication type:
- Article
37
Neonatal intraventricular haemorrhage associated with maternal use of paroxetine.
- Published in:
- British Journal of Clinical Pharmacology, 2003, v. 56, n. 5, p. 581, doi. 10.1046/j.1365-2125.2003.01906.x
- By:
- Publication type:
- Article
38
Book Review Drugs Handbook 2003.
- Published in:
- 2003
- By:
- Publication type:
- Book Review
39
Book Review Principles of Clinical Pharmacology.
- Published in:
- 2003
- By:
- Publication type:
- Book Review
40
Letter to the Editors Serum sickness-like reaction associated with clopidogrel.
- Published in:
- 2003
- By:
- Publication type:
- Letter
41
Inhibitory effect of stiripentol on carbamazepine and saquinavir metabolism in human.
- Published in:
- British Journal of Clinical Pharmacology, 2003, v. 56, n. 5, p. 526, doi. 10.1046/j.0306-5251.2003.01919.x
- By:
- Publication type:
- Article
42
Free and bound propofol concentrations in human cerebrospinal fluid.
- Published in:
- British Journal of Clinical Pharmacology, 2003, v. 56, n. 5, p. 545, doi. 10.1046/j.1365-2125.2003.01920.x
- By:
- Publication type:
- Article
43
Quinine intoxications reported to the Scottish Poisons Information Bureau 1997–2002: a continuing problem.
- Published in:
- British Journal of Clinical Pharmacology, 2003, v. 56, n. 5, p. 576, doi. 10.1046/j.1365-2125.2003.01921.x
- By:
- Publication type:
- Article
44
An in vitro interethnic comparison of monoamine oxidase activities between Japanese and Caucasian livers using rizatriptan, a serotonin receptor 1B/1D agonist, as a model drug.
- Published in:
- British Journal of Clinical Pharmacology, 2003, v. 56, n. 5, p. 537, doi. 10.1046/j.1365-2125.2003.01922.x
- By:
- Publication type:
- Article
45
Evaluation of two carrier protein–angiotensin I conjugate vaccines to assess their future potential to control high blood pressure (hypertension) in man.
- Published in:
- British Journal of Clinical Pharmacology, 2003, v. 56, n. 5, p. 505, doi. 10.1046/j.1365-2125.2003.01926.x
- By:
- Publication type:
- Article
46
Steady-state pharmacokinetics and pharmacodynamics of cysteamine bitartrate in paediatric nephropathic cystinosis patients.
- Published in:
- British Journal of Clinical Pharmacology, 2003, v. 56, n. 5, p. 520, doi. 10.1046/j.1365-2125.2003.01927.x
- By:
- Publication type:
- Article
47
Human subcutaneous tissue distribution of fluconazole: comparison of microdialysis and suction blister techniques.
- Published in:
- British Journal of Clinical Pharmacology, 2003, v. 56, n. 5, p. 551, doi. 10.1046/j.1365-2125.2003.01930.x
- By:
- Publication type:
- Article
48
The effects of KT3-671, a new angiotensin II (AT 1) receptor blocker in mild to moderate hypertension.
- Published in:
- British Journal of Clinical Pharmacology, 2003, v. 56, n. 5, p. 513, doi. 10.1046/j.1365-2125.2003.01932.x
- By:
- Publication type:
- Article
49
Pathology of drug-associated gastrointestinal disease.
- Published in:
- British Journal of Clinical Pharmacology, 2003, v. 56, n. 5, p. 477, doi. 10.1046/j.1365-2125.2003.01980.x
- By:
- Publication type:
- Article
50
Biopsy assessment of drug efficacy in the gastrointestinal tract.
- Published in:
- British Journal of Clinical Pharmacology, 2003, v. 56, n. 5, p. 483, doi. 10.1046/j.1365-2125.2003.01981.x
- By:
- Publication type:
- Article